HUNTINGTON NATIONAL BANK - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$60
-93.6%
1
-92.3%
0.00%
Q2 2023$937
+1166.2%
13
+1200.0%
0.00%
Q1 2023$74
+10.4%
10.0%0.00%
Q4 2022$6710.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$0
-100.0%
1
-99.6%
0.00%
Q3 2020$23,000
-14.8%
244
+2.1%
0.00%
Q2 2020$27,000
+145.5%
239
+64.8%
0.00%
Q1 2020$11,000
-50.0%
145
-31.3%
0.00%
Q4 2019$22,000
-8.3%
211
-12.4%
0.00%
Q3 2019$24,000
-27.3%
241
-16.0%
0.00%
-100.0%
Q2 2019$33,000
+3.1%
287
+13.0%
0.00%0.0%
Q1 2019$32,000
+18.5%
254
+25.7%
0.00%
Q4 2018$27,000
-50.0%
202
+3.1%
0.00%
-100.0%
Q3 2018$54,000
+22.7%
196
-7.1%
0.00%0.0%
Q2 2018$44,000
-4.3%
211
-23.6%
0.00%0.0%
Q1 2018$46,000
-11.5%
276
-27.9%
0.00%0.0%
Q4 2017$52,0000.0%3830.0%0.00%0.0%
Q3 2017$52,000
+6.1%
383
-4.5%
0.00%0.0%
Q2 2017$49,000
+58.1%
401
+35.0%
0.00%0.0%
Q1 2017$31,000
+3.3%
297
+1.0%
0.00%0.0%
Q4 2016$30,000
-3.2%
294
-2.0%
0.00%0.0%
Q3 2016$31,000
+63.2%
300
+84.0%
0.00%
Q2 2016$19,000
+58.3%
163
+50.9%
0.00%
Q4 2015$12,0001080.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders